Контроль за розвитком та перебігом супутньої патології у хворих на артропатичний псоріаз
ОО Сизон, ВІ Степаненко - Український журнал дерматології …, 2014 - irbis-nbuv.gov.ua
Матеріали та методи. Комплексно обстежено 187 хворих на артропатичний псоріаз з
тривалістю захворювання від 8 до 24 років, у більшості з яких встановлено супутні …
тривалістю захворювання від 8 до 24 років, у більшості з яких встановлено супутні …
Lymphocyte resistance to lysophosphatidylcholine mediated apoptosis in atherosclerosis
N Zurgil, E Afrimzon, Y Shafran, O Shovman, B Gilburd… - Atherosclerosis, 2007 - Elsevier
OBJECTIVE: Apoptosis is being increasingly regarded as a key component in the
development and progression of atherosclerosis. Since it has become apparent that the …
development and progression of atherosclerosis. Since it has become apparent that the …
Association of killer cell immunoglobulin–like receptor genotypes with vascular arterial events and anticardiolipin antibodies in patients with lupus
SMA Toloza, FJ Pellett, V Chandran, D Ibanez… - Lupus, 2008 - journals.sagepub.com
To determine whether killer cell immunologlobulin–like receptor (KIR) genotypes are
associated with vasculitis, vascular arterial events or anticardiolipin (aCL) antibodies in …
associated with vasculitis, vascular arterial events or anticardiolipin (aCL) antibodies in …
The editor's roundtable: Cyclooxygenase-2 inhibitors and cardiovascular risk
RS Bresalier, VE Friedewald, RE Rakel… - American Journal of …, 2005 - ajconline.org
The Editor’s Roundtable: Cyclooxygenase-2 Inhibitors and Cardiovascular Risk - American
Journal of Cardiology Skip to Main Content Advertisement The American Journal of Cardiology® …
Journal of Cardiology Skip to Main Content Advertisement The American Journal of Cardiology® …
The ubiquitin‐proteasome system—micro target for macro intervention?
J Herrmann, A Ciechanover, LO Lerman… - International Journal of …, 2005 - Taylor & Francis
The ubiquitin‐proteasome system is the two sequential labeling and degradation system
that accounts for the degradation of 80–90% of all intracellular proteins. Based on the …
that accounts for the degradation of 80–90% of all intracellular proteins. Based on the …
Modulation of tachykinin and cytokine release in patients with coronary disease undergoing percutaneous revascularization
M Paroli, P Mariani, D Accapezzato, M D'Alessandro… - Clinical …, 2004 - Elsevier
Plasma levels of substance P (SP) and neurokinin A (NKA) tachykinin and of gamma
interferon (IFN-γ) and tumor necrosis factor alpha (TNF-α) cytokines were assayed in plasma …
interferon (IFN-γ) and tumor necrosis factor alpha (TNF-α) cytokines were assayed in plasma …
Enfermedades inflamatorias mediadas por inmunidad y otras comorbilidades en pacientes con psoriasis. Características basales de la cohorte de pacientes con …
F Vanaclocha, V Crespo-Erchiga… - Actas Dermo …, 2015 - Elsevier
Introducción y objetivos Los pacientes con psoriasis presentan con frecuencia
comorbilidades, incluyendo otras enfermedades inflamatorias mediadas por inmunidad …
comorbilidades, incluyendo otras enfermedades inflamatorias mediadas por inmunidad …